microRNA调控肝星状细胞活化干预肝癌癌前病变的研究进展

吴杰; 李京涛; 魏海梁; 闫曙光; 范妤; 郭英君; 常占杰

doi:10.3969/j.issn.1001-5256.2020.07.045

microRNA调控肝星状细胞活化干预肝癌癌前病变的研究进展

DOI: 10.3969/j.issn.1001-5256.2020.07.045

1. 陕西中医药大学第一临床医学院
2. 陕西中医药大学附属医院肝病科
3. 宁夏回族自治区人民医院肝病科

基金项目:

国家自然科学基金项目(81603612)；陕西省科技厅科研基金项目(2016SF-234、2018KJXX-093)；陕西省教育厅基金(16JK1212)；陕西省中管局基金(15-JC008)；陕西省“特支计划”区域发展人才项目(2017)；宁夏回族自治区自然科学基金(NZ17278)；陕西中医药大学学科创新团队建设项目(2019-YL05)；

详细信息

中图分类号: R735.7
计量
- 文章访问数: 1047
- HTML全文浏览量: 59
- PDF下载量: 152
- 被引次数: 0
出版历程
- 出版日期: 2020-07-20

Advances in the role of microRNA in the intervention of malignant transformation of precancerous lesions of the liver by regulating the activation of hepatic stellate cells

1. The First Clinical Medical College of Shaanxi University of Chinese Medicine, Xianyang, Shaanxi 712046, China; 2. Department of Hepatology, The Affiliated Hospital of Shaanxi University of Chinese Medicine, Xianyang, Shaanxi 712046, China; 3. The People’s Hospital of Ningxia Hui Autonomous Region, Yinchuan 750001, China

Research funding:

摘要

摘要:
在肝癌的进展中,其发生发展呈多阶段性:肝炎-肝硬化-肝癌癌前病变-肝癌。其中肝癌癌前病变恶性转变与肝星状细胞（HSC）活化密切相关,通过叙述活化的HSC与肝癌癌前病变细胞的产生、炎症纤维化微环境的形成,以及两者的相互作用。提出microRNAs可通过调控相关靶基因的表达,发挥调节HSC活化,进而影响肝癌癌前病变恶性转变的作用,这方面研究有望成为肝癌防治的新思路、新靶点。
- 肝肿瘤 /
- 癌前状态 /
- 肝星状细胞 /
- 微RNAs
Abstract:
The development and progression of liver cancer have the stages of hepatitis,liver cirrhosis,precancerous lesion,and liver cancer,among which the malignant transformation of precancerous lesions of liver cancer is closely associated with the activation of hepatic stellate cells( HSC). By describing the activation of HSC,the generation of precancerous cells of liver cancer,the formation of inflammatory fibrotic microenvironment,and the association between HSC activation and precancerous lesion,this article points out that microRNAs can affect the malignant transformation of precancerous lesion of liver cancer by regulating the expression of related target genes and HSC activation,and the research in this field is expected to provide new ideas and targets for the prevention and treatment of liver cancer.
- liver neoplasms /
- precancerous conditions /
- hepatic stellate cells /
- microRNAs

HTML全文

参考文献(47)

[1] MIRAL SG,AMY KK,SEAN MRK,et al.Hepatocellular carcinoma:From diagnosis to treatment[J].Surg Oncol,2016,25(2):74-85．

[2]Di TOMMASO L,SANGIOVANNI A,BORZIO M,et al.Advanced precancerous lesions in the liver[J].Best Pract Res Clin Gastroenterol,2013,27(2):269-284．

[3] Chinese Society of Liver Cancer,Chinese Anti-Cancer Association;Liver Cancer Study Group,Chinese Society of Hepatology,Chinese Medical Association;Chinese Society of Pathology,Chinese AntiCancer Association,et al.Evidence-based practice guidelines for the standardized pathological diagnosis of primary liver cancer in China(2015 update)[J].J Clin Hepatol,2015,31(6):833-839.(in Chinese)中国抗癌协中国抗癌协会肝癌专业委员会，中华医学会肝病学分会肝癌学组，中国抗癌协会病理专业委员会，等．原发性肝癌规范化病理诊断指南(2015年版)[J]．临床肝胆病杂志，2015,31(6):833-839．

[4] LI JT,WEI HL,YAN SG,et al.Transforming growth factor-beta1/Smad signaling pathway regulating precancerous lesions of cirrhosis-liver cancer[J].Chin Med J,2017,97(46):3671-3673.(in Chinese)李京涛，魏海梁，闫曙光，等．转化生长因子-β1/Smad信号通路调控肝硬化-肝癌癌前病变的研究进展[J]．中华医学杂志，2017,97(46):3671-3673．

[5]XIE J,LI LH.Inhibitory effect of dehydroandrographolide on hepatocyte apoptosis induced by carbon tetrachloride in hepatic fibrosis model mice and its mechanism[J].J Jilin Uni(Med Edit),2019,45(5):1009-1014.(in Chinese)谢婧，李丽华．脱水穿心莲内酯对四氯化碳诱导的肝纤维化模型小鼠肝细胞凋亡的抑制作用及其机制[J]．吉林大学学报(医学版)，2019,45(5):1009-1014．

[6]LEE UE,FRIEDMAN SL.Mechanisms of hepatic fibrogenesis[J].Best Pract Res Clin Gastroenterol,2011,25(2):195-206．

[7]MA HH,XIA CM.Research advances in the signaling pathways associated with the activation of hepatic stellate cells[J].Chin J Integr Tradit West Med Liver Dis,2019,29(4):380-382.(in Chinese)马会会，夏超明．肝星状细胞活化相关信号通路的研究进展[J]．中西医结合肝病杂志，2019,29(4):380-382．

[8] AMANN T,BATAILLE F,SPRUSS T,et al.Activated hepatic stellate cells promote tumorigenicity of hepatocellular carcinoma[J].Cancer Sci,2009,100(4):646-653．

[9] YAMAZAKI K,MASUGI Y,SAKAMOTO M.Molecular pathogenesis of hepatocellular carcinoma:Altering transforming growth factor-βsignaling in hepatocarcinogenesis[J].Dig Dis,2011,29(3):284-288．

[10]International Working Party.Terminology of nodular hepatocellular lesions[J].Hepatology,1995,22(3):983-993．

[11]AIHARA T,NOGUCHI S,SASAKI Y,et al.Clonal analysis of precancerous lesion of hepatocellular carcinoma[J].Gastroenterology,1996,111(2):455-461．

[12] OHB K,KIM YJ,PARK YN,et al.Quantitative assessment of h TERT mRNA expression in dysplastic nodules of HBV related hepatocar cinogenesis[J].Am J Gastroenterol,2006,101(4):831-838．

[13]ZHOU KQ,ZHOU C.Research advances in dysplastic nodules in the liver[J].J Surg Concepts Pract,2018,23(3):286-288.(in Chinese)周恺乾，周成．肝异型增生结节的研究进展[J]．外科理论与实践，2018,23(3):286-288．

[14] DONG H.Features of early-stage small hepatocellular carcinoma and microsatellite alterations of precancerous lesion and their clinicopathological significance[D].Shanghai:The Second Military Medical University,2007.(in Chinese)董辉．早期小肝癌与癌前病变微卫星变异特点及其临床病理学意义的研究[D]．上海:第二军医大学，2007．

[15]SHIM YH,YOON GS,CHOI HJ,et al.p16 Hypermethylation in the early stage of hepatitis B virus-associated hepatocarcinogenesis[J].Cancer Lett,2003,190(2):213-219．

[16]XIANG MX,LIU ZJ.Research advances in the association of Kupffer cells with the development,progression,and metastasis of liver cancer[J].J Mod Med Health,2016,32(18):2833-2836.(in Chinese)向明祥，刘作金．Kupffer细胞与肝癌的发生、发展、转移关系的研究进展[J]．现代医药卫生，2016,32(18):2833-2836．

[17] SANTAMATO A,FRANSVEA E,DITURI F,et al.Hepatic stellate cells stimulate HCC cell migration via laminin-5 production[J].Clin Sci(Lond),2011,121(4):159-168．

[18]JIAO JZ,LI JT,YAN SG,et al.Current research status of precancerous dysplastic nodules in hepatocellular carcinoma[J].J Clin Hepatol,2017,33(5):974-978.(in Chinese)焦俊喆，李京涛，闫曙光，等．肝细胞癌癌前异型增生结节的研究现状[J]．临床肝胆病杂志，2017,33(5):974-978．

[19]ZHOU WX,LIANG ZY,LIU TH.Clinicopathology of hepatocyte dysplasia nodules[J].Concord Med J,2012,3(1):68-71.(in Chinese)周炜洵，梁智勇，刘彤华．肝细胞异型增生结节的临床病理[J]．协和医学杂志，2012,3(1):68-71．

[20]KEW MC.The role of cirrhosis in the etiology of hepatocellular carcinoma[J].J Gastrointest Cancer,2014,45(1):12-21．

[21]MORMONE E,GEORGE J,NIETO N.Molecular pathogenesis of hepatic fibrosis and current therapeutic approaches[J].Chem Biol Interact,2011,193(3):225-231．

[22]WANG KQ,XING YL,YU ZW,et al.Mechanism research of miR-182 promoting proliferation,invasion and migration of Hep G2 cells by activating PI3k/AKT signaling pathway[J].Mod Oncol,2020,28(11):1855-1859.(in Chinese)王开琼，邢贻雷，余智威，等．miR-182激活PI3K/AKT信号通路促进肝癌Hep G2细胞增殖、侵袭和迁移的机制研究[J]．现代肿瘤医学，2020,28(11):1855-1859．

[23] HSIEH CC,HUNG CH,CHIANG M,et al.Hepatic stellate cells enhance liver cancer progression by inducing myeloid-derived suppressor cells through interleukin-6 signaling[J].Int J Mol Sci,2019,20(20):5079．

[24] XIA Y,CHEN R,YE SL,et al.Inhibition of T-cell responses by intratumoral hepatic stellate cells contribute to migration and invasion of hepatocellular carcinoma[J].Clin Exp Metastasis,2011,28(7):661-674．

[25]GIANNELLI G,BERGAMINI C,FRANSVEA E,et al.Laminin-5with transforming growth factor-beta1 induces epithelial to mesenchymal transition in hepatocellular carcinoma[J].Gastroenterology,2005,129(5):1375-1383．

[26]GIANNELLI G,ANTONACI S.Biological and clinical relevance of Laminin-5 in cancer[J].Clin Exp Metastasis,2000,18(6):439-443．

[27]MISHRA S,YADAV T,RANI V.Exploring miRNA based approaches in cancer diagnostics and therapeutics[J].Crit Rev Oncol Hematol,2016,98:12-23．

[28]FAN W,XU ZL,WANG DW,et al.The expressions of microRNA-509in serum and its relationship with prognosis of patients with hepatocellular carcinoma[J].J Clin Exp Med,2019,18(3):249-252.(in Chinese)范维，许芝林，汪大伟，等．微小miRNA-509在肝癌患者血清中的表达及其与预后的关系[J]．临床和实验医学杂志，2019,18(3):249-252．

[29] ZHANG Y.Identification,identification and differential expression analysis of tea tree microRNA and its target genesunder low temperature stress[D].Nanjing:Nanjing Agricultural University,2014.(in Chinese)张玥．低温胁迫下茶树microRNA及其靶基因的识别、鉴定与差异表达分析[D]．南京:南京农业大学，2014．

[30] MA L,YANG X,WEI R,et al.MicroRNA-214 promotes hepatic stellate cell activation and liver fibrosis by suppressing Sufu expression[J].Cell Death Dis,2018,9(7):718．

[31] DERYNCK R,BUDI EH.Specificity,versatility,and control of TGF-βfamily signaling[J].Sci Signal,2019,12(570):eaav5183．

[32] DEWIDAR B,MEYER C,DOOLEY S,et al.TGF-βin hepatic stellate cell activation and liver fibrogenesis-updated 2019[J].Cells,2019,8(11):1419．

[33] YU F,GUO Y,CHEN B,et al.MicroRNA-17-5p activates hepatic stellate cells through targeting of Smad7[J].Lab Invest,2015,95(7):781-789．

[34]ZHU J,ZHANG Z,ZHANG Y,et al.MicroRNA-212 activates hepatic stellate cells and promotes liver fibrosis via targeting SMAD7[J].Biochem Biophys Res Commun,2018,496(1):176-183．

[35]SHEN QY,LUO WS.Research progress of miRNAs in hepatic fibrosis[J].J World Latest Med Inf,2019,19(80):64-66.(in Chinese)申秋艳，罗伟生．miRNAs在肝纤维化中的研究进展[J]．世界最新医学信息文摘，2019,19(80):64-66．

[36]JU D,LI JT,HAN M,et al.Research progress on hepatic stellate cells affecting cirrhosis and precancerous lesions of hepatocellular carcinoma through the TGFβ1-PI3K/AKT signaling pathway[J].J Clin Hepatol,2018,34(1):192-194.(in Chinese)鞠迪，李京涛，韩曼，等．肝星状细胞通过TGFβ1-PI3K/AKT信号通路影响肝硬化-肝细胞癌癌前病变的研究进展[J]．临床肝胆病杂志，2018,34(1):192-194．

[37] FERNNDEZ-RAMOS D,FERNNDEZ-TUSSY P,LOPITZ-OTSOA F,et al.MiR-873-5p acts as an epigenetic regulator in early stages of liver fibrosis and cirrhosis[J].Cell Death Dis,2018,9(10):958．

[38]ZOU Y,CAI Y,LU D,et al.MicroRNA-146a-5p attenuates liver fibrosis by suppressing profibrogenic effects of TGFβ1 and lipopolysaccharide[J].Cell Signal,2017,39:1-8．

[39] WANG Y,DU J,NIU X,et al.MiR-130a-3p attenuates activation and induces apoptosis of hepatic stellate cells in nonalcoholic fibrosing steatohepatitis by directly targeting TGFBR1 and TGFBR2[J].Cell Death Dis,2017,8(5):e2792．

[40] HYUN J,WANG S,KIM J,et al.MicroRNA-378 limits activation of hepatic stellate cells and liver fibrosis by suppressing Gli3 expression[J].Nat Commun,2016,7:10993．

[41] YU F,FAN X,CHEN B,et al.Activation of hepatic stellate cells is inhibited by microRNA-378a-3p via Wnt10a[J].Cell Physiol Biochem,2016,39(6):2409-2420．

[42] LIAO X,ZHAN W,TIAN T,et al.MicroRNA-326 attenuates hepatic stellate cell activation and liver fibrosis by inhibiting TLR4 signaling[J].J Cell Biochem,2019.[Online ahead of print]

[43]HOU C,WEI HL,LI JT,et al.Advances in non-coding RNA regulating Kupffer cell polarization in intervention of malignant transformation of precancerous lesions of liver[J].Cancer Res Prevent Treat,2019,46(9):851-855.(in Chinese)侯婵，魏海梁，李京涛，等．非编码RNA调控Kupffer细胞极化干预肝癌癌前病变恶变的研究进展[J]．肿瘤防治研究，2019,46(9):851-855．

[44] MARTINEZ-NUNEZ RT,LOUAFI F,SANCHEZ-ELSNER T.The interleukin 13(IL-13)pathway in human macrophages is modulated by microRNA-155 via direct targeting of interleukin 13 receptor alpha1(IL13Ralpha1)[J].J Biol Chem,2011,286(3):1786-1794．

[45]GU W.miR-124 mediate the regulation of ICAM-1 to MCP-1 and polarization of macrophage[D].Wuhan:Huazhong Agricultural University,2017.(in Chinese)顾玮．miR-124介导ICAM-1对MCP-1的调节作用和对巨噬细胞极化的影响[D]．武汉:华中农业大学，2017．

[46]ZHOU L,LIU S,HAN M,et al.miR-185 inhibits fibrogenic activation of hepatic stellate cells and prevents liver fibrosis[J].Mol Ther Nucleic Acids,2018,10:91-102．

[47]LI MM.microRNA-340 inhibits hepatic stellate cells activation by targeting SPP1[D].Tangshan:North China University of Science and Technology,2019.(in Chinese)李明明．miR-340通过靶定SPP1抑制肝星状细胞活化[D]．唐山:华北理工大学，2019.

施引文献

资源附件(0)

访问统计